CN114787362A - 检测细胞外嘌呤受体配体的系统和导入该系统的非人动物 - Google Patents

检测细胞外嘌呤受体配体的系统和导入该系统的非人动物 Download PDF

Info

Publication number
CN114787362A
CN114787362A CN202080086064.1A CN202080086064A CN114787362A CN 114787362 A CN114787362 A CN 114787362A CN 202080086064 A CN202080086064 A CN 202080086064A CN 114787362 A CN114787362 A CN 114787362A
Authority
CN
China
Prior art keywords
protein
genetically modified
ligand
human animal
reporter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080086064.1A
Other languages
English (en)
Chinese (zh)
Inventor
和田学
和田直子
上田乙也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to CN202510799633.1A priority Critical patent/CN120683228A/zh
Publication of CN114787362A publication Critical patent/CN114787362A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90241—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN202080086064.1A 2019-12-13 2020-12-11 检测细胞外嘌呤受体配体的系统和导入该系统的非人动物 Pending CN114787362A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202510799633.1A CN120683228A (zh) 2019-12-13 2020-12-11 检测细胞外嘌呤受体配体的系统和导入该系统的非人动物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-225404 2019-12-13
JP2019225404 2019-12-13
PCT/JP2020/046301 WO2021117874A1 (ja) 2019-12-13 2020-12-11 細胞外プリン受容体リガンドを検出するシステムおよび当該システムを導入した非ヒト動物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202510799633.1A Division CN120683228A (zh) 2019-12-13 2020-12-11 检测细胞外嘌呤受体配体的系统和导入该系统的非人动物

Publications (1)

Publication Number Publication Date
CN114787362A true CN114787362A (zh) 2022-07-22

Family

ID=76330019

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202080086064.1A Pending CN114787362A (zh) 2019-12-13 2020-12-11 检测细胞外嘌呤受体配体的系统和导入该系统的非人动物
CN202510799633.1A Pending CN120683228A (zh) 2019-12-13 2020-12-11 检测细胞外嘌呤受体配体的系统和导入该系统的非人动物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202510799633.1A Pending CN120683228A (zh) 2019-12-13 2020-12-11 检测细胞外嘌呤受体配体的系统和导入该系统的非人动物

Country Status (5)

Country Link
US (1) US20230000063A1 (https=)
EP (1) EP4074821A4 (https=)
JP (2) JP7765290B2 (https=)
CN (2) CN114787362A (https=)
WO (1) WO2021117874A1 (https=)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1378593A (zh) * 1999-08-20 2002-11-06 约翰斯霍普金斯大学医学院 构建融合文库的方法和组合物及该文库的用途
TW200402424A (en) * 2002-04-10 2004-02-16 Aventis Pharma Inc A novel G protein-coupled purinergic receptor, GAVE17
JP2015517565A (ja) * 2012-05-25 2015-06-22 グローバラコーン リミテッド 疼痛の治療のためのジヌクレオシドポリリン酸
WO2017204318A1 (ja) * 2016-05-27 2017-11-30 塩野義製薬株式会社 １，２，４－トリアジン誘導体
JP2019092417A (ja) * 2017-11-21 2019-06-20 国立大学法人 筑波大学 遺伝子改変非ヒト動物及びその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
DE69942334D1 (de) 1998-03-02 2010-06-17 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US20030104526A1 (en) 1999-03-24 2003-06-05 Qiang Liu Position dependent recognition of GNN nucleotide triplets by zinc fingers
ITRM20050252A1 (it) 2005-05-23 2006-11-24 Aequotech S R L Proteine chimeriche per la misurazione delle concentrazioni di atp nello spazio pericellulare e metodo di screening relativo.
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
HUE041436T2 (hu) 2009-12-10 2019-05-28 Univ Minnesota Tal-effektor-közvetített DNS-módosítás
AU2013359262C1 (en) 2012-12-12 2021-05-13 Massachusetts Institute Of Technology CRISPR-Cas component systems, methods and compositions for sequence manipulation
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
WO2015108102A1 (ja) 2014-01-15 2015-07-23 国立大学法人 群馬大学 Ａｔｐ可視化動物およびその用途

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1378593A (zh) * 1999-08-20 2002-11-06 约翰斯霍普金斯大学医学院 构建融合文库的方法和组合物及该文库的用途
TW200402424A (en) * 2002-04-10 2004-02-16 Aventis Pharma Inc A novel G protein-coupled purinergic receptor, GAVE17
JP2015517565A (ja) * 2012-05-25 2015-06-22 グローバラコーン リミテッド 疼痛の治療のためのジヌクレオシドポリリン酸
WO2017204318A1 (ja) * 2016-05-27 2017-11-30 塩野義製薬株式会社 １，２，４－トリアジン誘導体
JP2019092417A (ja) * 2017-11-21 2019-06-20 国立大学法人 筑波大学 遺伝子改変非ヒト動物及びその使用

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ARI: "《Signal Transduction Pathways，Mechanisms and Diseases》", 31 December 2010, 斯普林格出版公司, pages: 96 *
CARSTEN HOFFMANN 等: ""Agonist-selective, Receptor-specific Interaction of Human P2Y Receptors with-Arrestin-1 and -2"", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》, vol. 283, no. 45, 7 November 2008 (2008-11-07), pages 30938 *
JOLIEN STORME 等: ""Molecular dissection of the human A3 adenosine receptor coupling with b-arrestin2"", 《BIOCHEMICAL PHARMACOLOGY》, vol. 148, 5 January 2018 (2018-01-05), pages 2 *
JOLIEN STORME: ""β-Arrestin coupling to Purinergic Receptors:Glo with the Flow?"", 《BASE》, 31 December 2018 (2018-12-31), pages 1 - 2 *
LYNN WELTER-STAHL等: ""Expression of purinergic receptors and modulation of P2X7 function by the inflammatory cytokine IFNgamma in human epithelial cells"", 《BIOCHIM BIOPHYS ACTA》, vol. 1788, no. 5, pages 1176 - 1187 *
P.MICHAEL CONN: "《Methods in enzymology:G protein Coupled Receptors :Modeling, Activation, Interactions and virtual screening》", 31 December 2013, 爱思维尔出版公司, pages: 191 - 192 *
王友升等: ""第二信使环腺苷酸和环鸟苷酸检测方法研究进展"", 《食品科学技术学报》, vol. 35, no. 06, pages 48 - 54 *

Also Published As

Publication number Publication date
JPWO2021117874A1 (https=) 2021-06-17
EP4074821A1 (en) 2022-10-19
JP2025157431A (ja) 2025-10-15
WO2021117874A1 (ja) 2021-06-17
US20230000063A1 (en) 2023-01-05
EP4074821A4 (en) 2024-01-17
CN120683228A (zh) 2025-09-23
JP7765290B2 (ja) 2025-11-06

Similar Documents

Publication Publication Date Title
Mansfield et al. Emerging insights in senescence: pathways from preclinical models to therapeutic innovations
DE69831136T2 (de) Eiweisbruchstückergänzungstests zum nachweis biomolekularinteraktionen
JP5802674B2 (ja) 蛍光共鳴エネルギー移動の原理に基づく一分子型ｆｒｅｔバイオセンサーのリンカー
JP2004529614A (ja) 動脈平滑筋及び静脈平滑筋並びにそれらの利用
CN116075318A (zh) 抗nme抗体及治疗癌症或癌症转移的方法
JPWO2006035741A1 (ja) Ｅｓ細胞特異的発現遺伝子及びその利用
JP4832299B2 (ja) キメラ癌モデル
KR102296075B1 (ko) epcam 유전자 변이 제브라피쉬 및 이의 용도
JP7765290B2 (ja) 細胞外プリン受容体リガンドを検出するシステムおよび当該システムを導入した非ヒト動物
HK40072081A (en) System for detecting extracellular purinergic receptor ligand, and non human animal having the system introduced thereinto
WO2024191355A1 (en) Methods and uses involving aquaporin-5 (aqp5)
HK40125771A (zh) 检测细胞外嘌呤受体配体的系统和导入该系统的非人动物
JP5093776B2 (ja) 病態の状態をリアルタイムで観察可能なモデル動物とそれを可能にする遺伝子構築物及びその使用
US20250116658A1 (en) Compositions and methods for in vivo protease profiling by immune cell display
JP4545142B2 (ja) 製薬学的活性化合物のｉｎｖｉｖｏでの迅速同定のための動物モデル
KR102133179B1 (ko) Irx1 유전자-녹아웃 형질전환 제브라피쉬 모델 및 이의 용도
US20110217239A1 (en) System and method of evaluating a protein of interest on tumor growth inhibition while following the tumor in vivo or in vitro
US20150037251A1 (en) Mammalian homologues of flower, their use in cancer diagnostics, prevention and treatment
JP5624469B2 (ja) 神経活動を可視化するプローブ
Lee Exploring the Role of FGFR2c Misregulation in Syndromic Craniosynostosis
Kocher DAPK3 Suppresses Mammary Acini Morphogenesis and is Required for Mouse Development
Marvin et al. A lineage tracing based TGF-β/SMAD3 activity tracer
Cooper Novel developmental roles of EphA receptors
JP2007159473A (ja) 内因性オピオイドペプチド産生ニューロンの可視化に利用可能なトランスジェニック非ヒト動物およびその利用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40072081

Country of ref document: HK

RJ01 Rejection of invention patent application after publication

Application publication date: 20220722

RJ01 Rejection of invention patent application after publication